Literature DB >> 3215745

A prospective clinical and epidemiological study of head injuries in northern Italy: the Comune of Ravenna.

F Servadei1, G Ciucci, G Piazza, G Bianchedi, G Rebucci, G Gaist, F Taggi.   

Abstract

An analysis of all the head injuries occurring during one year within a well-defined geographical area was conducted in the region served by the Ravenna City Hospital in Northern Italy. This hospital does not have a neurosurgical service, so that patients suspected of having neurosurgical problems are transferred to the neurosurgical unit in Bologna, a distance of 65 Km (40 mi.). Of the 1468 head-injured patients seen in the emergency room, 644 (44%) were hospitalized, with an incidence of 372/10(5) pop/year) and were subjected to X-ray study of the skull (83%), EEG (64%), and CT scan (7.5%). 9 patients were transferred to the neurosurgical unit as emergencies on a clinical basis only, all were found to harbor cerebral lesions, and 7 were operated on. Of the patients hospitalized and subjected to CT scan in Ravenna, only one (0.17%) was found to have a lesion necessitating surgery. Mortality was 7.2% with 83% of these patients dying before admission. Three-month follow-up examination revealed the persistence of some symptoms in 20% of the 379 patients examined, but 91% had already returned to their previous occupation. Analysis of the risk factors present in the patients admitted to a non-specialized hospital seems to show that the presence of skull fracture, abnormal EEG, and alteration of the clinical condition constitute the indications for a CT scan, in order to detect the presence of intracranial lesions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3215745     DOI: 10.1007/bf02337162

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  21 in total

1.  The outcome from severe head injury with early diagnosis and intensive management.

Authors:  D P Becker; J D Miller; J D Ward; R P Greenberg; H F Young; R Sakalas
Journal:  J Neurosurg       Date:  1977-10       Impact factor: 5.115

2.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

3.  Management of head injuries.

Authors:  G Teasdale
Journal:  Practitioner       Date:  1982-10

4.  Extradural hematoma: toward zero mortality. A prospective study.

Authors:  A P Bricolo; L M Pasut
Journal:  Neurosurgery       Date:  1984-01       Impact factor: 4.654

5.  Influence of the type of intracranial lesion on outcome from severe head injury.

Authors:  T A Gennarelli; G M Spielman; T W Langfitt; P L Gildenberg; T Harrington; J A Jane; L F Marshall; J D Miller; L H Pitts
Journal:  J Neurosurg       Date:  1982-01       Impact factor: 5.115

6.  Improved confidence of outcome prediction in severe head injury. A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressure.

Authors:  R K Narayan; R P Greenberg; J D Miller; G G Enas; S C Choi; P R Kishore; J B Selhorst; H A Lutz; D P Becker
Journal:  J Neurosurg       Date:  1981-06       Impact factor: 5.115

7.  Costs and benefits of skull radiography for head injury. A national study by the Royal College of Radiologists.

Authors: 
Journal:  Lancet       Date:  1981-10-10       Impact factor: 79.321

8.  Sequelae associated with head injuries in patients who were not hospitalized: a follow-up survey.

Authors:  R Coonley-Hoganson; N Sachs; B T Desai; S Whitman
Journal:  Neurosurgery       Date:  1984-03       Impact factor: 4.654

9.  The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974.

Authors:  J F Annegers; J D Grabow; L T Kurland; E R Laws
Journal:  Neurology       Date:  1980-09       Impact factor: 9.910

10.  Epidemiology and sequelae of head injury in San Marino Republic.

Authors:  F Servadei; S Bastianelli; G Naccarato; G Staffa; G Morganti; G Gaist
Journal:  J Neurosurg Sci       Date:  1985 Oct-Dec       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.